IMRIS appoints Kelly McNeill as Chief Financial Officer

    WINNIPEG, Aug. 25 /CNW/ - (TSX:IM) - IMRIS Inc. (TSX: IM) ("IMRIS" or the
"Company") today announced the appointment of Kelly McNeill as Executive Vice
President, Finance and Administration and Chief Financial Officer. Mr. McNeill
replaces Ron Sabourin who is retiring after serving as IMRIS's CFO since its
founding in 2005.
    Mr. McNeill, a Chartered Accountant, brings a wealth of experience to
IMRIS, having worked in the biotechnology and manufacturing industries as well
as in both publicly traded and privately held companies. Most recently, Mr.
McNeill held the position of Chief Financial Officer with Resverlogix Corp., a
publicly traded biotechnology company. He is a member of the Institute of
Chartered Accountants of Alberta and holds a Masters of Accountancy and
Bachelor of Commerce (Honours) from the University of Manitoba.
    "With a strong financial background and significant experience in the
biotech and manufacturing sectors, as well as expertise across all aspects of
public company finance, Kelly is well suited to contribute to IMRIS's success
going forward," said David Graves, President & CEO. "We are very pleased to
welcome him to the IMRIS team."
    "I also want to take this opportunity to recognize the outstanding
contribution Ron Sabourin has made to our company and the tremendous role he
has played in advancing our business to where we are today," added Mr. Graves.
"On behalf of the entire IMRIS team, I would like to thank Ron for his
service, and wish him all the best in his retirement."
    Mr. McNeill will assume his position effective September 21, 2009.

    About IMRIS

    IMRIS (TSX: IM) is a global leader in providing fully integrated,
advanced surgical imaging solutions. The company's flagship product,
IMRISneuro, utilizes patented technology that allows a high field MRI scanner
to be moved in to the operating room on demand, providing imaging during the
surgical procedure without compromising patient safety. This unique and
innovative system has been validated by leading neurosurgeons for use in
world-class neuroscience centers.

For further information:

For further information: Brad Woods, Director Investor Relations &
Corporate Communications, IMRIS Inc., Tel: (204) 480-7094, Email:

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890